PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of frontcellneuroLink to Publisher's site
 
Front Cell Neurosci. 2017; 11: 210.
Published online 2017 July 17. doi:  10.3389/fncel.2017.00210
PMCID: PMC5511838

Pannexins Are Potential New Players in the Regulation of Cerebral Homeostasis during Sleep-Wake Cycle

Abstract

During brain homeostasis, both neurons and astroglia release ATP that is rapidly converted to adenosine in the extracellular space. Pannexin-1 (Panx1) hemichannels represent a major conduit of non-vesicular ATP release from brain cells. Previous studies have shown that Panx1−/− mice possess severe disruption of the sleep-wake cycle. Here, we review experimental data supporting the involvement of pannexins (Panx) in the coordination of fundamental sleep-associated brain processes, such as neuronal activity and regulation of cerebrovascular tone. Panx1 hemichannels are likely implicated in the regulation of the sleep-wake cycle via an indirect effect of released ATP on adenosine receptors and through interaction with other somnogens, such as IL-1β, TNFα and prostaglandin D2. In addition to the recently established role of Panx1 in the regulation of endothelium-dependent arterial dilation, similar signaling pathways are the major cellular component of neurovascular coupling. The new discovered role of Panx in sleep regulation may have broad implications in coordinating neuronal activity and homeostatic housekeeping processes during the sleep-wake cycle.

Keywords: pannexins, non-REM sleep, purinergic system, cytokines, prostaglandin D2, glymphatic system, endothelium, neurovascular coupling

Introduction

Pannexins are a family of proteins that were discovered as a result of human and invertebrate gene homology analysis (Panchin et al., 2000). The members of this family, especially pannexin-1 (Panx1), is implicated in a number of vital biological functions and the development of several pathological mechanisms (Orellana et al., 2012; Prochnow et al., 2012; Penuela et al., 2013; Velasquez and Eugenin, 2014; Dalkara and Alarcon-Martinez, 2015). Although mouse Panx1-knockout (Panx1KO) models demonstrate a rather mild phenotype with no obvious alteration, as reported initially (Bargiotas et al., 2012; Dvoriantchikova et al., 2012), an essential physiological role of Panx1 was highlighted in a recent report of a human patient with a homozygous missense Panx1 variant (c.650G→A). This loss-of-function mutation resulted in extensive multisystem dysfunctions (Shao et al., 2016).

Panx1 is highly expressed in the brain (Bruzzone et al., 2003; Baranova et al., 2004), particularly in neurons (Ray et al., 2005; Zoidl et al., 2007), microglia and astrocytes (Huang et al., 2007), as well as in the cerebral vasculature (Burns et al., 2012). Its expression in the hypothalamus suggests a role in regulation of fundamental homeostatic processes (Ray et al., 2005; Hodson et al., 2015). This has been confirmed in a recent study highlighting an essential role of Panx1 in the regulation of the sleep-wake cycle (Kovalzon et al., 2017). Although not characterized mechanistically, this new function of Panx1 is attributed to its intimate integration with the brain purinergic system that plays a central role in regulation of sleep-wake cycle (Dunwiddie and Masino, 2001; Blanco-Centurion et al., 2006; Krueger et al., 2010; Blutstein and Haydon, 2013; Huang et al., 2014; Lazarus and Urade, 2015; Petit and Magistretti, 2016).

In the homeostatic brain, astrocytes are the main source of extracellular purines such as ATP and adenosine (Halassa et al., 2009; Bazargani and Attwell, 2016; Clasadonte et al., 2016). The mammalian purinergic system possesses two mechanisms for release of intracellular ATP: a transmembrane channel-mediated release and vesicular release (Lohman and Isakson, 2014; Burnstock, 2017). It is currently established that, along with some connexins, Panx1 hemichannels are the major conduit of non-vesicular release of intracellular ATP into the extracellular medium (Suadicani et al., 2012; Beckel et al., 2014). The non-vesicular release is responsible for ATP secretion in a circadian manner from astrocytes (Marpegan et al., 2011). Astrocytes are the main source of extracellular purines in the CNS (Halassa et al., 2009; Bazargani and Attwell, 2016; Clasadonte et al., 2016). Consistently, a recent report showed a role of Panx1 hemichannels in glucocorticoid-regulated diurnal oscillations of ATP release in spinal astrocytes (Koyanagi et al., 2016). To conclude, the central role of Panx in ATP secretion likely underlies Panx1 contribution to purinergic regulation of sleep-wake cycle.

In this article, we sought to survey different cellular and molecular mechanisms potentially connecting Panx1 hemichannels to regulation of the sleep-wake cycle. At present, it is clear from the literature that in addition to neuronal manifestations, natural sleep also engages with other physiological processes, such as cerebral blood circulation, brain ionic homeostasis and glymphatic clearance (Klingelhöfer et al., 1995; Braun et al., 1997; Xie et al., 2013; Jessen et al., 2015; Plog et al., 2015). Here, we review the well-known functional relationship between these processes and Panx and hypothesize on potential new ones.

Pannexins in Neuronal Manifestations of Sleep

Despite recent progress in the understanding of the neural mechanisms of sleep regulation, the molecular nature of the “need for sleep” that gradually increases during wakefulness remains uncharacterized. However, we do know that adenosine is the principle endogenous somnogen in the brain milieu (Dunwiddie and Masino, 2001; Krueger et al., 2011, 2016; Porkka-Heiskanen and Kalinchuk, 2011; Tupone et al., 2013; Huang et al., 2014; Lazarus and Urade, 2015). In the anterior hypothalamus, daily fluctuations in adenosine concentration are associated with the sleep-wake cycle (Dunwiddie and Masino, 2001; Blanco-Centurion et al., 2006). Conversely, blockade of adenosine signaling through genetic ablation of A1 and A2A receptors disrupts the sleep-wake cycle (Wei et al., 2011; Lazarus and Urade, 2015). A2 receptors are involved in the inhibition of brain stem activation system via enhancement of sleep-promoting GABA/galaninergic neurons in the ventrolateral preoptic area (VLPO; Obal and Krueger, 2003). In addition, cholinergic wake-promoting neurons in this brain area are inhibited through A1 receptors (Obal and Krueger, 2003).

Panx1 channels are likely involved in the regulation of the sleep-wake cycle via an indirect effect of released ATP on adenosine receptors. In a recent study, Kovalzon et al. (2017) revealed that Panx1KO mice have significantly prolonged periods of activity and spend less time in non-rapid eye movement (NREM) sleep, particularly during the dark (active) period compared with control C57Bl/6 mice. The effects of Panx1 knockout were similar to the influence of adenosine receptor antagonists such as caffeine and theophylline (Lazarus and Urade, 2015), which links NREM sleep alterations in Panx1KO mice to downregulation of adenosine signaling. In addition to the shorter NREM sleep, Panx1KO mice demonstrated a significant increase in movement activity. This is not surprising, because the blockade of adenosine signaling in the brain can dramatically alter behavioral patterns via effects on synaptic plasticity and learning (Ledent et al., 1997; Dunwiddie and Masino, 2001; Prochnow et al., 2012).

Along with that, sleep rebound after a 6-h sleep deprivation during the daylight remained unchanged in Panx1KO mice as compared to the control animals (Kovalzon et al., 2017). Presumably, the influence of Panx1 on homeostatic sleep following sleep deprivation can be masked by adenosine contributed by the pathways distinct from Panx1-mediated release of ATP. Indeed, our research showed that the release of ATP from the Panx1KO astrocytes is significantly reduced but not eliminated, as compared to WT mice (Beckel et al., 2014). The residual release can result in accumulation of adenosine during sleep deprivation, sufficient to induce a somnogenic effect in KO mice. Such explanation is supported by the experiments with a different mouse model, the ENT1 knockout mice, also possessing a decrease in cerebral adenosine level. These mice were also shown to have the lower baseline level of NREM sleep as well as the lack of any changes in sleep rebound (Kim et al., 2015). Therefore, the decreased basal level of adenosine does not necessarily translate into altered response to sleep deprivation.

In addition to the role in adenosine signaling, Panx may be involved in sleep/wake alterations that are mediated by some prostaglandins (PGs) and cytokines. Along with adenosine, PGD2, TNFα and IL-1β are among the most potent sleep-inducing substances (Fredholm, 2011; Krueger et al., 2011; Jewett and Krueger, 2012). Endogenous IL-1β and TNFα cytokines are expressed in various brain regions and different cell types, including neurons, microglia and astrocytes (Breder et al., 1993; Inoue et al., 2000; Vitkovic et al., 2000). Neurons release these factors in response to injury, ischemia and danger factors in a Panx1-dependent manner (de Rivero Vaccari et al., 2008, 2014; Abulafia et al., 2009; Dvoriantchikova et al., 2012). PGD2 and IL-1β signaling pathways are tightly linked to purinergic signaling through the inflammasome complex (Lutz et al., 2013; Cauwels et al., 2014; Meng et al., 2014; Zhang et al., 2015).

Unrelated to inflammation, PGD2, TNFα and IL-1β are considered as fundamental players in the physiological regulation of normal sleep through a link to purinergic signaling (Figure (Figure1;1; Hayaishi, 2000, 2011; Krueger et al., 2011, 2016; Urade and Hayaishi, 2011; Jewett and Krueger, 2012). Circulating cytokines may influence brain homeostasis by passing through the blood brain barrier either in the circumventricular organs or by activating receptors on the capillary endothelium, where they induce a secondary release of PGs and other signaling molecules (Konsman et al., 2002; Krueger et al., 2011). IL-1β and TNFα are upregulated in the brain during prolonged wakefulness, and the injection of these cytokines increases NREM sleep. Consistently, knockout mice lacking TNFα or IL-1β receptors spend less time in NREM sleep (Baracchi and Opp, 2008; Krueger et al., 2011, 2016; Jewett and Krueger, 2012).

Figure 1
Pannexins (Panx) in purinergic control of non-rapid eye movement (NREM) sleep. In neurons and astrocytes, Panx proteins form plasma membrane hemichannels that are highly permeable for ATP. ATP is rapidly converted by ectonucleotidases to adenosine (Ado), ...

The somnogenic activity of cytokines, such as IL-1β and TNFα, is linked to PGD2 production. IL-1β-induced NREM sleep is suppressed by inhibitors of cyclooxygenase, the key enzyme of PG production, while activation of the DP1/DP2 receptors increases the production of IL-1β and TNFα (Urade and Hayaishi, 2011). Interestingly, PGD2 in the brain is produced in the leptomeninges, rather than in the brain parenchyma (Hayaishi, 2000, 2011; Urade and Hayaishi, 2011). PGD2 is secreted from leptomeninges into the cerebrospinal fluid, and circulates throughout the ventricular and subarachnoidal spaces. The receptors for PGD2 are localized in a small area of leptomeninges on the ventrorostral surface of the basal forebrain just ventral to the VLPO.

The key role of Panx1 in ATP release during neuronal and glial transmission links this plasma membrane hemichannel to cytokine release and implicates it in sleep regulation via this pathway. Glial cells upregulate and release IL-1β and TNFα in response to extracellular ATP that binds to P2 receptors (Bianco et al., 2005; Krueger et al., 2010; Verderio and Matteoli, 2011). The somnogenic effect of PGD2 is also tightly linked to purinergic signaling, since it increases the extracellular level of adenosine in the brain. Adenosine is proposed to be the key signaling molecule that mediates the somnogenic effect of PGD2 (Mizoguchi et al., 2001; Hayaishi, 2011; Urade and Hayaishi, 2011; Lazarus and Urade, 2015). Consistent with this, the somnogenic effect of PGD2 infusion is attenuated by genetic ablation of A2A-receptors (Zhang et al., 2017). Activation of PGD receptors is followed by an increase in adenosine, which activates sleep-promoting neurons in the VLPO, and at the same time, down-regulates the histaminergic wake-promoting neurons in the tuberomammillary nuclei of posterior hypothalamus (Hayaishi, 2000, 2011; Urade and Hayaishi, 2011). These effects are abolished in DP receptor knockout mice.

Therefore, Panx1 hemichannels are likely implicated in the regulation of the sleep-wake cycle via ATP release. ATP is converted to somnogenic adenosine and both purines interact with other somnogens, such as IL-1β, TNFα and PGD2.

Are Pannexins Involved in Regulation of the Glymphatic System?

The novel role of brain glia and our current understanding of the functional significance of sleep has been recently highlighted by the group led by Maiken Nedergaard (Xie et al., 2013; Jessen et al., 2015; Plog et al., 2015). They pioneered the discovery and characterization of the glymphatic (glial-lymphatic) system, a novel pathway of metabolic waste clearance in the brain. The activity of the glymphatic system during NREM sleep causes significant changes in the volume and ionic composition of the extracellular fluid in the brain (Iliff et al., 2012; Xie et al., 2013; Bedussi et al., 2015; Ding et al., 2016). The signal for glymphatic system activation is likely defined by the fall of noradrenergic tone that occurs at the onset of NREM sleep (O’Donnell et al., 2015). Fully activated during NREM sleep, the glymphatic system provides removal of potentially toxic waste and metabolites accumulated during prolonged wakefulness.

Considering that the astrocytic purinergic signaling system is closely linked to the regulation of the sleep-wake cycle (Blanco-Centurion et al., 2006; Halassa et al., 2009; Lazarus and Urade, 2015; Bazargani and Attwell, 2016; Clasadonte et al., 2016), we hypothesize that pannexin hemichannels may constitute an important functional component of the glymphatic system. Importantly, pannexin hemichannels were recently shown to be involved in transporting lactate across the astrocytic membrane (Karagiannis et al., 2016). Remarkably, rapid and sustained decline of lactate concentration marks NREM sleep (Naylor et al., 2012) and removal of lactate from the sleeping brain constitutes one of the key functions of glymphatic transport (Lundgaard et al., 2017).

Pannexins in Control of Cerebrovascular Tone

Cerebral blood flow varies during the sleep-wake cycle. In comparison with wakefulness, total cerebral blood flow during periods of NREM sleep is significantly reduced (Klingelhöfer et al., 1995; Braun et al., 1997), but blood distribution within certain brain regions can vary significantly (Braun et al., 1997). Such cyclic changes in cerebral blood flow are associated with specific alterations in cerebrovascular tone, which may be regulated by the pannexin/purinergic system. Panx are widely expressed in the vascular bed and represent an essential pathway for the release of vasoactive purines (Billaud et al., 2012; Burns et al., 2012; Lohman et al., 2012a; Begandt et al., 2017). ATP and adenosine can dilate cerebral arteries and arterioles by activating endothelial P2 (P2Y1, P2Y2, P2Y4, P2Y6 and P2X4 subtypes and A2a/b receptors, respectively; Ralevic and Dunn, 2015; Burnstock, 2017). Remarkably, endothelium sensitivity to ATP during the sleep-wake cycle is most pronounced at the beginning of the active phase (Durgan et al., 2016). Sleep disorders disrupt such cyclic variations of the dilator response to ATP (Durgan et al., 2016) and reduce its magnitude (Crossland et al., 2013).

In the endothelium, the Panx1 channel restrains vasoconstriction by regulating the secretion of vasorelaxing molecules by several proposed mechanisms. First, Panx1 activation could underlie endothelium sensitivity to shear fluid stress through their functional link to the PIEZO1 cation channel, a putative mechanosensor of endothelial cells (EC; Wang et al., 2016). This is followed by ATP release, eNOS phosphorylation, and production of nitric oxide (NO), a powerful vasodilator. Panx1 also mediates the eNOS-stimulating effects of calcitonin gene-related peptide (CGRP), a transmitter of sensory nerves (Gaete et al., 2014), which densely innervate pial arteries and arterioles (Hamel, 2006). Furthermore, Panx1 hemichannels may be co-activated with NMDA receptors by glutamate (Sandilos and Bayliss, 2012; Weilinger et al., 2012), a principal central nervous system excitatory transmitter that can induce NO-dependent relaxation of cerebral arteries (LeMaistre et al., 2012). Along with that, high levels of NO can act as a negative feedback loop to inhibit Panx1 hemichannels through the conventional cyclic GMP—protein kinase G pathway (Poornima et al., 2015) or by S-nitrosylation of Panx1 cysteine residues (Lohman et al., 2012b).

Besides modulation of NO-dependent signaling pathways, Panx participate in an endothelium-derived hyperpolarization (EDH) mechanism, which is independent of NO and PG (Edwards et al., 2010). Arteries of Panx1KO mice demonstrate an impaired endothelium-dependent relaxation (Gaynullina et al., 2014) due to the shortage of EDH (Gaynullina et al., 2015). In wild type mice, the EDH-component is inhibited by apyrase and an adenosine receptor antagonist, indicating the involvement of Panx1-mediated ATP release from EC. Extracellular ATP may provide an additional rise of cytoplasmic Ca2+ in EC through P2 receptors (Burnstock, 2017). Besides that, adenosine produced by ectonucleotidases, which are abundantly expressed in vascular cells (Kauffenstein et al., 2010; Zukowska et al., 2015) may activate the endothelium through A2 receptors (Burnstock, 2017). Functional deficiency of these mechanisms in Panx1KO mice supports Panx1 participation in endothelium-dependent control of vascular tone. Because a pannexin/ATP feed-forward mechanism can be activated by an increase in intracellular Ca2+ (Locovei et al., 2006b), this mechanism could underlie the generation of Ca2+ waves, that propagate along the endothelial cell layer and coordinate responses of smaller and larger resistance arteries (Locovei et al., 2006a).

Panx1 is also implicated as an important regulator of vasoconstriction. In smooth muscle cell (SMC)s of peripheral arteries Panx1 co-localizes with α1D-adrenergic receptors and secretes ATP that, in turn, activates P2Y-receptors and potentiates adrenergic vasoconstriction (Billaud et al., 2011, 2015). Importantly, Panx1-mediated vasoconstriction is specific to α1D-adrenergic stimulation and is lacking during smooth muscle stimulation with high-K+ depolarization, endothelin-1, or serotonin (Billaud et al., 2011, 2015). The latter observation questioned the role of this mechanism in cerebral vasoregulation, as cerebral arteries of different species, including humans, have demonstrated low reactivity to agonists of α-adrenoceptors (Högestätt and Andersson, 1984; Thorin et al., 2003; Bai et al., 2004).

Small parenchymal arterioles possess a unique control mechanism, known as neurovascular coupling, that allows them to be regulated locally by surrounding neurons and astrocytes and provide adequate blood supply to active neurons (Figure (Figure2).2). The mechanisms of neurovascular coupling are strongly dependent on purinergic signaling from neurons and astrocytes to vascular cells and pericytes (Pelligrino et al., 2011; Mishra et al., 2016; Mishra, 2017). While not fully established, a role of Panx in these processes is likely, as vasorelaxing factors derived from glial cells are similar to above-discussed factors of EC, and both cooperate with extracellular ATP (Vetri et al., 2011; Gaynullina et al., 2015; Longden et al., 2016; Mishra, 2017; Figure Figure2).2). Several lines of evidence support potential vasorelaxation mechanisms that involve Panx1. First, the signals from astrocytes and interneurons to vascular SMCs can be transmitted by such established endothelium-derived regulators as NO and arachidonic acid (AA) metabolites (Longden et al., 2016; Mishra et al., 2016; Mishra, 2017). Second, vasomotor signals from astrocytes involve an EDH-like mechanism with participation of Ca2+-activated K+ channels in astrocytic endfeet, K+ accumulation in local space between the feet and the SMC, and activation of KIR channels and Na+/K+-ATPase in vascular SMCs with further hyperpolarization and relaxation (Longden et al., 2016). A moderate rise in extracellular K+ can activate pannexin channels (Suadicani et al., 2012; Wang et al., 2014) and may represent an additional pathway of Panx1-dependent regulation of cerebrovascular tone.

Figure 2
Purinergic mechanisms of cerebrovascular dilation: the role of endothelium (left) and astrocytes/neurons (right). Left: ATP is released from activated endothelial cells (EC) via Panx or Connexin (Cx) hemichannels and activates P2 receptors (subtypes P2Y1, ...

Potentially, purine/pannexin-dependent mechanisms of neurovascular coupling may vary in activity during the sleep-wake cycle. Thus, a somnogenic effect of glucose in mice is associated with an increase in adenosine concentration, and, consequently, dilation of parenchymal arterioles specifically in VLPO (Scharbarg et al., 2016). Moreover, the vasodilator effect of adenosine is dependent on the phase of sleep-wake cycle being significantly higher at the time of passive behavior in comparison to the active period. These data suggest an involvement of Panx in the control of sleep-wake cycle via the regulation of local blood flow.

Conclusions

Recent observations suggest that Panx are involved in the regulation of the sleep-wake cycle. If experimentally validated, this will have broad implications in coordination of sleep-wake cycle-related changes in neuronal activity and homeostatic housekeeping processes, such as glymphatic clearance, regulation of cerebrovascular tone and many others. Therefore, various aspects of sleep-wake brain homeostasis including oscillating neuronal and glial activity and brain-vascular dynamics could all be linked by the same pannexin functions. In the near future, we expect that new evidence will be revealed that supports sleep-related functions of the pannexin/purinergic system that can potentially be used to design novel therapeutics to treat multiple types of sleep disorders.

Author Contributions

VIS, YP, OST, DG and VMK contributed to the conception, literature review, writing and revising of this article.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Glossary

Abbreviations

CGPR
calcitonin gene-related peptide
EDH
endothelium-derived hyperpolarization
EETs
epoxyeicosatrienoic acids
eNOS
endothelial nitric oxide synthase
NMDA
N-methyl-D-aspartate
NO
nitric oxide
NREM
non-rapid eye movement
Panx1
pannexin-1
Panx1KO
Panx1-knockout
PGs
prostaglandins
SKCa, IKCa and BKCa
calcium-activated potassium channels of small, intermediate and big conductance, respectively
VLPO
ventrolateral preoptic area.

Footnotes

Funding. This study was supported by the Russian Science Foundation (grant N17-15-01433 to VIS, YP, OST and VMK) and NIH NEI (grant EY0521517 to VIS).

References

  • Abulafia D. P., de Rivero Vaccari J. P., Lozano J. D., Lotocki G., Keane R. W., Dietrich W. D. (2009). Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow Metab. 29, 534–544. 10.1038/jcbfm.2008.143 [PubMed] [Cross Ref]
  • Bai N., Moien-Afshari F., Washio H., Min A., Laher I. (2004). Pharmacology of the mouse-isolated cerebral artery. Vascul. Pharmacol. 41, 97–106. 10.1016/j.vph.2004.07.001 [PubMed] [Cross Ref]
  • Baracchi F., Opp M. R. (2008). Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 β receptor 1 and tumor necrosis factor-α receptor 1. Brain. Behav. Immun. 22, 982–993. 10.1016/j.bbi.2008.02.001 [PMC free article] [PubMed] [Cross Ref]
  • Baranova A., Ivanov D., Petrash N., Pestova A., Skoblov M., Kelmanson I., et al. . (2004). The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 83, 706–716. 10.1016/j.ygeno.2003.09.025 [PubMed] [Cross Ref]
  • Bargiotas P., Krenz A., Monyer H., Schwaninger M. (2012). Functional outcome of pannexin-deficient mice after cerebral ischemia. Channels 6, 453–456. 10.4161/chan.22315 [PMC free article] [PubMed] [Cross Ref]
  • Bazargani N., Attwell D. (2016). Astrocyte calcium signaling: the third wave. Nat. Neurosci. 19, 182–189. 10.1038/nn.4201 [PubMed] [Cross Ref]
  • Beckel J. M., Argall A. J., Lim J. C., Xia J., Lu W., Coffey E. E., et al. . (2014). Mechanosensitive release of adenosine 5′-triphosphate through pannexin channels and mechanosensitive upregulation of pannexin channels in optic nerve head astrocytes: a mechanism for purinergic involvement in chronic strain. Glia 62, 1486–1501. 10.1002/glia.22695 [PMC free article] [PubMed] [Cross Ref]
  • Bedussi B., van Lier M. G. J. B., Bartstra J. W., de Vos J., Siebes M., VanBavel E., et al. . (2015). Clearance from the mouse brain by convection of interstitial fluid towards the ventricular system. Fluids Barriers CNS 12:23. 10.1186/s12987-015-0019-5 [PMC free article] [PubMed] [Cross Ref]
  • Begandt D., Good M. E., Keller A. S., DeLalio L. J., Rowley C., Isakson B. E., et al. . (2017). Pannexin channel and connexin hemichannel expression in vascular function and inflammation. BMC Cell Biol. 18:2. 10.1186/s12860-016-0119-3 [PMC free article] [PubMed] [Cross Ref]
  • Bianco F., Pravettoni E., Colombo A., Schenk U., Möller T., Matteoli M., et al. . (2005). Astrocyte-derived ATP induces vesicle shedding and IL-1 β release from microglia. J. Immunol. 174, 7268–7277. 10.4049/jimmunol.174.11.7268 [PubMed] [Cross Ref]
  • Billaud M., Chiu Y.-H., Lohman A. W., Parpaite T., Butcher J. T., Mutchler S. M., et al. . (2015). A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells. Sci. Signal. 8:ra17. 10.1126/scisignal.2005824 [PMC free article] [PubMed] [Cross Ref]
  • Billaud M., Lohman A. W., Straub A. C., Looft-Wilson R., Johnstone S. R., Araj C. A., et al. . (2011). Pannexin1 regulates α1-adrenergic receptor- mediated vasoconstriction. Circ. Res. 109, 80–85. 10.1161/CIRCRESAHA.110.237594 [PMC free article] [PubMed] [Cross Ref]
  • Billaud M., Sandilos J. K., Isakson B. E. (2012). Pannexin 1 in the regulation of vascular tone. Trends Cardiovasc. Med. 22, 68–72. 10.1016/j.tcm.2012.06.014 [PMC free article] [PubMed] [Cross Ref]
  • Blanco-Centurion C., Xu M., Murillo-Rodriguez E., Gerashchenko D., Shiromani A. M., Salin-Pascual R. J., et al. . (2006). Adenosine and sleep homeostasis in the basal forebrain. J. Neurosci. 26, 8092–8100. 10.1093/sleep/29.11.1387 [PubMed] [Cross Ref]
  • Blutstein T., Haydon P. G. (2013). The Importance of astrocyte-derived purines in the modulation of sleep. Glia 61, 129–139. 10.1002/glia.22422 [PMC free article] [PubMed] [Cross Ref]
  • Braun A. R., Balkin T. J., Wesenten N. J., Carson R. E., Varga M., Baldwin P., et al. . (1997). Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 120, 1173–1197. 10.1093/brain/120.7.1173 [PubMed] [Cross Ref]
  • Breder C. D., Tsujimoto M., Terano Y., Scott D. W., Saper C. B. (1993). Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 337, 543–567. 10.1002/cne.903370403 [PubMed] [Cross Ref]
  • Bruzzone R., Hormuzdi S. G., Barbe M. T., Herb A., Monyer H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. U S A 100, 13644–13649. 10.1073/pnas.2233464100 [PubMed] [Cross Ref]
  • Burns A. R., Phillips S. C., Sokoya E. M. (2012). Pannexin protein expression in the rat middle cerebral artery. J. Vasc. Res. 49, 101–110. 10.1159/000332329 [PMC free article] [PubMed] [Cross Ref]
  • Burnstock G. (2017). Purinergic signaling in the cardiovascular system. Circ. Res. 120, 207–228. 10.1161/CIRCRESAHA.116.309726 [PubMed] [Cross Ref]
  • Cauwels A., Rogge E., Vandendriessche B., Shiva S., Brouckaert P. (2014). Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis. 5:e1102. 10.1038/cddis.2014.70 [PMC free article] [PubMed] [Cross Ref]
  • Clasadonte J., Morel L., Barrios-Camacho C. M., Chiang M. S. R., Zhang J., Iyer L., et al. . (2016). Molecular analysis of acute and chronic reactive astrocytes in the pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 91, 315–325. 10.1016/j.nbd.2016.03.024 [PubMed] [Cross Ref]
  • Crossland R. F., Durgan D. J., Lloyd E. E., Phillips S. C., Reddy A. K., Marrelli S. P., et al. . (2013). A new rodent model for obstructive sleep apnea: effects on ATP-mediated dilations in cerebral arteries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R334–R342. 10.1152/ajpregu.00244.2013 [PubMed] [Cross Ref]
  • Dalkara T., Alarcon-Martinez L. (2015). Cerebral microvascular pericytes and neurogliovascular signaling in health and disease. Brain Res. 1623, 3–17. 10.1016/j.brainres.2015.03.047 [PubMed] [Cross Ref]
  • de Rivero Vaccari J. P., Dietrich W. D., Keane R. W. (2014). Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J. Cereb. Blood Flow Metab. 34, 369–375. 10.1038/jcbfm.2013.227 [PMC free article] [PubMed] [Cross Ref]
  • de Rivero Vaccari J. P., Lotocki G., Marcillo A. E., Dietrich W. D., Keane R. W. (2008). A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci. 28, 3404–3414. 10.1523/JNEUROSCI.0157-08.2008 [PubMed] [Cross Ref]
  • Ding F., O’Donnell J., Xu Q., Kang N., Goldman N., Nedergaard M. (2016). Changes in the composition of brain interstitial ions control the sleep-wake cycle. Science 352, 550–555. 10.1126/science.aad4821 [PMC free article] [PubMed] [Cross Ref]
  • Dunwiddie T. V., Masino S. A. (2001). The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31–55. 10.1146/annurev.neuro.24.1.31 [PubMed] [Cross Ref]
  • Durgan D. J., Crossland R. F., Bryan R. M., Jr. (2016). The rat cerebral vasculature exhibits time-of-day-dependent oscillations in circadian clock genes and vascular function that are attenuated following obstructive sleep apnea. J. Cereb. Blood Flow Metab. 1:271678X16675879. 10.1177/0271678x16675879 [PubMed] [Cross Ref]
  • Dvoriantchikova G., Ivanov D., Barakat D., Grinberg A., Wen R., Slepak V. Z., et al. . (2012). Genetic ablation of Pannexin1 protects retinal neurons from ischemic injury. PLoS One 7:e31991. 10.1371/journal.pone.0031991 [PMC free article] [PubMed] [Cross Ref]
  • Edwards G., Félétou M., Weston A. H. (2010). Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch. 459, 863–879. 10.1007/s00424-010-0817-1 [PubMed] [Cross Ref]
  • Fredholm B. (2011). Physiological and pathophysiological roles of adenosine. Sleep Biol. Rhythms 9, 24–28. 10.1111/j.1479-8425.2010.00460.x [Cross Ref]
  • Gaete P. S., Lillo M. A., Figueroa X. F. (2014). Functional role of connexins and pannexins in the interaction between vascular and nervous system. J. Cell. Physiol. 229, 1336–1345. 10.1002/jcp.24563 [PubMed] [Cross Ref]
  • Gaynullina D., Shestopalov V. I., Panchin Y., Tarasova O. S. (2015). Pannexin 1 facilitates arterial relaxation via an endothelium-derived hyperpolarization mechanism. FEBS Lett. 589, 1164–1170. 10.1016/j.febslet.2015.03.018 [PubMed] [Cross Ref]
  • Gaynullina D., Tarasova O. S., Kiryukhina O. O., Shestopalov V. I., Panchin Y. (2014). Endothelial function is impaired in conduit arteries of pannexin1 knockout mice. Biol. Direct 9:8. 10.1186/1745-6150-9-8 [PMC free article] [PubMed] [Cross Ref]
  • Halassa M. M., Florian C., Fellin T., Munoz J. R., Lee S.-Y., Abel T., et al. . (2009). Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 61, 213–219. 10.1016/j.neuron.2008.11.024 [PMC free article] [PubMed] [Cross Ref]
  • Hamel E. (2006). Perivascular nerves and the regulation of cerebrovascular tone. J. Appl. Physiol. 100, 1059–1064. 10.1152/japplphysiol.00954.2005 [PubMed] [Cross Ref]
  • Hayaishi O. (2000). Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 355, 275–280. 10.1098/rstb.2000.0564 [PMC free article] [PubMed] [Cross Ref]
  • Hayaishi O. (2011). Humoral mechanisms of sleep-wake regulation: historical review of prostaglandin D2 and related substances. Sleep Biol. Rhythms 9, 3–9. 10.1111/j.1479-8425.2010.00448.x [Cross Ref]
  • Hodson D. J., Legros C., Desarménien M. G., Guérineau N. C. (2015). Roles of connexins and pannexins in (neuro)endocrine physiology. Cell. Mol. Life Sci. 72, 2911–2928. 10.1007/s00018-015-1967-2 [PubMed] [Cross Ref]
  • Högestätt E. D., Andersson K. E. (1984). On the postjunctional α-adrenoreceptors in rat cerebral and mesenteric arteries. J. Auton. Pharmacol. 4, 161–173. 10.1111/j.1474-8673.1984.tb00093.x [PubMed] [Cross Ref]
  • Huang Y., Grinspan J. B., Abrams C. K., Scherer S. S. (2007). Pannexin1 is expressed by neurons and glia but does not form functional gap junctions. Glia 55, 46–56. 10.1002/glia.20435 [PubMed] [Cross Ref]
  • Huang Z.-L., Zhang Z., Qu W.-M. (2014). Chapter Fourteen-Roles of adenosine and its receptors in sleep-wake regulation. Int. Rev. Neurobiol. 119, 349–371. 10.1016/B978-0-12-801022-8.00014-3 [PubMed] [Cross Ref]
  • Iliff J. J., Wang M., Liao Y., Plogg B. A., Peng W., Gundersen G. A., et al. . (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 4:147ra111. 10.1126/scitranslmed.3003748 [PMC free article] [PubMed] [Cross Ref]
  • Inoue J., Ishida T., Tsukamoto N., Kobayashi N., Naito A., Azuma S., et al. . (2000). Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14–24. 10.1006/excr.1999.4733 [PubMed] [Cross Ref]
  • Jessen N. A., Munk A. S. F., Lundgaard I., Nedergaard M. (2015). The glymphatic system: a beginner’s guide. Neurochem. Res. 40, 2583–2599. 10.1007/s11064-015-1581-6 [PMC free article] [PubMed] [Cross Ref]
  • Jewett K. A., Krueger J. M. (2012). Humoral sleep regulation; interleukin-1 and tumor necrosis factor. Vitam. Horm. 89, 241–257. 10.1016/B978-0-12-394623-2.00013-5 [PMC free article] [PubMed] [Cross Ref]
  • Karagiannis A., Sylantyev S., Hadjihambi A., Hosford P. S., Kasparov S., Gourine A. V. (2016). Hemichannel-mediated release of lactate. J. Cereb. Blood Flow Metab. 36, 1202–1211. 10.1177/0271678X15611912 [PMC free article] [PubMed] [Cross Ref]
  • Kauffenstein G., Drouin A., Thorin-Trescases N., Bachelard H., Robaye B., D’Orléans-Juste P., et al. . (2010). NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc. Res. 85, 204–213. 10.1093/cvr/cvp265 [PMC free article] [PubMed] [Cross Ref]
  • Kim T., Ramesh V., Dworak M., Choi D. S., McCarley R. W., Kalinchuk A. V., et al. . (2015). Disrupted sleep-wake regulation in type 1 equilibrative nucleoside transporter knockout mice. Neuroscience 303, 211–219. 10.1016/j.neuroscience.2015.06.037 [PMC free article] [PubMed] [Cross Ref]
  • Klingelhöfer J., Hajak G., Matzander G., Schulz-Varszegi M., Sander D., Rüther E., et al. . (1995). Dynamics of cerebral blood flow velocities during normal human sleep. Clin. Neurol. Neurosurg. 97, 142–148. 10.1016/0303-8467(95)00030-n [PubMed] [Cross Ref]
  • Konsman J. P., Parnet P., Dantzer R. (2002). Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25, 154–159. 10.1016/s0166-2236(00)02088-9 [PubMed] [Cross Ref]
  • Kovalzon V. M., Moiseenko L. S., Ambaryan A. V., Kurtenbach S., Shestopalov V. I., Panchin Y. V. (2017). Sleep-wakefulness cycle and behavior in pannexin1 knockout mice. Behav. Brain Res. 318, 24–27. 10.1016/j.bbr.2016.10.015 [PubMed] [Cross Ref]
  • Koyanagi S., Kusunose N., Taniguchi M., Akamine T., Kanado Y., Ozono Y., et al. . (2016). Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia. Nat. Commun. 7:13102. 10.1038/ncomms13102 [PMC free article] [PubMed] [Cross Ref]
  • Krueger J. M., Clinton J. M., Winters B. D., Zielinski M. R., Taishi P., Jewett K. A., et al. . (2011). Involvement of cytokines in slow wave sleep. Prog. Brain Res. 193, 39–47. 10.1016/B978-0-444-53839-0.00003-X [PMC free article] [PubMed] [Cross Ref]
  • Krueger J. M., Frank M. G., Wisor J. P., Roy S. (2016). Sleep function: toward elucidating an enigma. Sleep Med. Rev. 28, 46–54. 10.1016/j.smrv.2015.08.005 [PMC free article] [PubMed] [Cross Ref]
  • Krueger J. M., Taishi P., De A., Davis C. J., Winters B. D., Clinton J., et al. . (2010). ATP and the purine type 2X7 receptor affect sleep. J. Appl. Physiol. (1985) 109, 1318–1327. 10.1152/japplphysiol.00586.2010 [PubMed] [Cross Ref]
  • Lazarus M., Urade Y. (2015). “Adenosinergic regulation of sleep-wake behavior in the basal ganglia,” in The Adenosinergic System, Current Topics in Neurotoxicity 10, eds Morelli M., Simola N., Wardas J., editors. (Switzerland: Springer International Publishing; ), 309–326. 10.1007/978-3-319-20273-0_15 [Cross Ref]
  • Ledent C., Vaugeois J. M., Schiffmann S. N., Pedrazzini T., El Yacoubi M., Vanderhaeghen J. J., et al. . (1997). Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674–678. 10.1038/41771 [PubMed] [Cross Ref]
  • LeMaistre J. L., Sanders S. A., Stobart M. J., Lu L., Knox J. D., Anderson H. D., et al. . (2012). Coactivation of NMDA receptors by glutamate and d -serine induces dilation of isolated middle cerebral arteries. J. Cereb. Blood Flow Metab. 32, 537–547. 10.1038/jcbfm.2011.161 [PMC free article] [PubMed] [Cross Ref]
  • Locovei S., Bao L., Dahl G. (2006a). Pannexin 1 in erythrocytes: function without a gap. Proc. Natl. Acad. Sci. U S A 103, 7655–7659. 10.1073/pnas.0601037103 [PubMed] [Cross Ref]
  • Locovei S., Wang J., Dahl G. (2006b). Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett. 580, 239–244. 10.1016/j.febslet.2005.12.004 [PubMed] [Cross Ref]
  • Lohman A. W., Billaud M., Straub A. C., Johnstone S. R., Best A. K., Lee M., et al. . (2012a). Expression of pannexin isoforms in the systemic murine arterial network. J. Vasc. Res. 49, 405–416. 10.1159/000338758 [PMC free article] [PubMed] [Cross Ref]
  • Lohman A. W., Weaver J. L., Billaud M., Sandilos J. K., Griffiths R., Straub A. C., et al. . (2012b). S-Nitrosylation inhibits pannexin 1 channel function. J. Biol. Chem. 287, 39602–39612. 10.1074/jbc.M112.397976 [PMC free article] [PubMed] [Cross Ref]
  • Lohman A. W., Isakson B. E. (2014). Differentiating connexin hemichannels and pannexin channels in cellular ATP release. FEBS Lett. 588, 1379–1388. 10.1016/j.febslet.2014.02.004 [PMC free article] [PubMed] [Cross Ref]
  • Longden T. A., Hill-Eubanks D. C., Nelson M. T. (2016). Ion channel networks in the control of cerebral blood flow. J. Cereb. Blood Flow Metab. 36, 492–512. 10.1177/0271678X15616138 [PMC free article] [PubMed] [Cross Ref]
  • Lundgaard I., Lu M. L., Yang E., Peng W., Mestre H., Hitomi E., et al. . (2017). Glymphatic clearance controls state-dependent changes in brain lactate concentration. J. Cereb. Blood Flow Metab. 37, 2112–2124. 10.1177/0271678x16661202 [PubMed] [Cross Ref]
  • Lutz S. E., González-Fernández E., Ventura J. C., Pérez-Samartín A., Tarassishin L., Negoro H., et al. . (2013). Contribution of pannexin1 to experimental autoimmune encephalomyelitis. PLoS One 8:e66657. 10.1371/journal.pone.0066657 [PMC free article] [PubMed] [Cross Ref]
  • Marpegan L., Swanstrom A. E., Chung K., Simon T., Haydon P. G., Khan S. K., et al. . (2011). Circadian regulation of ATP release in astrocytes. J. Neurosci. 31, 8342–8350. 10.1523/JNEUROSCI.6537-10.2011 [PMC free article] [PubMed] [Cross Ref]
  • Meng X. F., Wang X. L., Tian X. J., Yang Z. H., Chu G. P., Zhang J., et al. . (2014). Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose. Mol. Neurobiol. 49, 673–684. 10.1007/s12035-013-8551-2 [PubMed] [Cross Ref]
  • Mishra A. (2017). Binaural blood flow control by astrocytes: listening to synapses and the vasculature. J. Physiol. 595, 1885–1902. 10.1113/JP270979 [PubMed] [Cross Ref]
  • Mishra A., Reynolds J. P., Chen Y., Gourine A. V., Rusakov D. A., Attwell D. (2016). Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles. Nat. Neurosci. 19, 1619–1627. 10.1038/nn.4428 [PMC free article] [PubMed] [Cross Ref]
  • Mizoguchi A., Eguchi N., Kimura K., Kiyohara Y., Qu W. M., Huang Z. L., et al. . (2001). Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U S A 98, 11674–11679. 10.1073/pnas.201398898 [PubMed] [Cross Ref]
  • Naylor E., Aillon D. V., Barrett B. S., Wilson G. S., Johnson D. A., Johnson D. A., et al. . (2012). Lactate as a biomarker for sleep. Sleep 35, 1209–1222. 10.5665/sleep.2072 [PubMed] [Cross Ref]
  • O’Donnell J., Ding F., Nedergaard M. (2015). Distinct functional states of astrocytes during sleep and wakefulness: is norepinephrine the master regulator? Curr. Sleep Med. Rep. 1, 1–8. 10.1007/s40675-014-0004-6 [PMC free article] [PubMed] [Cross Ref]
  • Obal F., Jr., Krueger J. M. (2003). Biochemical regulation of non-rapid-eye-movement sleep. Front. Biosci. 8, d520–d550. 10.2741/1033 [PubMed] [Cross Ref]
  • Orellana J. A., von Bernhardi R., Giaume C., Sáez J. C. (2012). Glial hemichannels and their involvement in aging and neurodegenerative diseases. Rev. Neurosci. 23, 163–177. 10.1515/revneuro-2011-0065 [PubMed] [Cross Ref]
  • Panchin Y., Kelmanson I., Matz M., Lukyanov K., Usman N., Lukyanov S. (2000). A ubiquitous family of putative gap junction molecules. Curr. Biol. 10, R473–R474. 10.1016/s0960-9822(00)00576-5 [PubMed] [Cross Ref]
  • Pelligrino D. A., Vetri F., Xu H.-L. (2011). Purinergic mechanisms in gliovascular coupling. Semin. Cell Dev. Biol. 22, 229–236. 10.1016/j.semcdb.2011.02.010 [PMC free article] [PubMed] [Cross Ref]
  • Penuela S., Gehi R., Laird D. W. (2013). The biochemistry and function of pannexin channels. Biochim. Biophys. Acta 1828, 15–22. 10.1016/j.bbamem.2012.01.017 [PubMed] [Cross Ref]
  • Petit J.-M., Magistretti P. J. (2016). Regulation of neuron-astrocyte metabolic coupling across the sleep-wake cycle. Neuroscience 323, 135–156. 10.1016/j.neuroscience.2015.12.007 [PubMed] [Cross Ref]
  • Plog B. A., Dashnaw M. L., Hitomi E., Peng W., Liao Y., Lou N., et al. . (2015). Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J. Neurosci. 35, 518–526. 10.1523/JNEUROSCI.3742-14.2015 [PMC free article] [PubMed] [Cross Ref]
  • Poornima V., Vallabhaneni S., Mukhopadhyay M., Bera A. K. (2015). Nitric oxide inhibits the pannexin 1 channel through a cGMP-PKG dependent pathway. Nitric Oxide 47, 77–84. 10.1016/j.niox.2015.04.005 [PubMed] [Cross Ref]
  • Porkka-Heiskanen T., Kalinchuk A. V. (2011). Adenosine, energy metabolism and sleep homeostasis. Sleep Med. Rev. 15, 123–135. 10.1016/j.smrv.2010.06.005 [PubMed] [Cross Ref]
  • Prochnow N., Abdulazim A., Kurtenbach S., Wildförster V., Dvoriantchikova G., Hanske J., et al. . (2012). Pannexin1 stabilizes synaptic plasticity and is needed for learning. PLoS One 7:e51767. 10.1371/journal.pone.0051767 [PMC free article] [PubMed] [Cross Ref]
  • Ralevic V., Dunn W. R. (2015). Purinergic transmission in blood vessels. Auton. Neurosci. 191, 48–66. 10.1016/j.autneu.2015.04.007 [PubMed] [Cross Ref]
  • Ray A., Zoidl G., Weickert S., Wahle P., Dermietzel R. (2005). Site-specific and developmental expression of pannexin1 in the mouse nervous system. Eur. J. Neurosci. 21, 3277–3290. 10.1111/j.1460-9568.2005.04139.x [PubMed] [Cross Ref]
  • Sandilos J. K., Bayliss D. A. (2012). Physiological mechanisms for the modulation of pannexin 1 channel activity. J. Physiol. 590, 6257–6266. 10.1113/jphysiol.2012.240911 [PubMed] [Cross Ref]
  • Scharbarg E., Daenens M., Lemaître F., Geoffroy H., Guille-Collignon M., Gallopin T., et al. . (2016). Astrocyte-derived adenosine is central to the hypnogenic effect of glucose. Sci. Rep. 6:19107. 10.1038/srep19107 [PMC free article] [PubMed] [Cross Ref]
  • Shao Q., Lindstrom K., Shi R., Kelly J., Schroeder A., Juusola J., et al. . (2016). A germline variant in the PANX1 gene has reduced channel function and is associated with multisystem dysfunction. J. Biol. Chem. 291, 12432–12443. 10.1074/jbc.M116.717934 [PMC free article] [PubMed] [Cross Ref]
  • Suadicani S. O., Iglesias R., Wang J., Dahl G., Spray D. C., Scemes E. (2012). ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes. Glia 60, 1106–1116. 10.1002/glia.22338 [PMC free article] [PubMed] [Cross Ref]
  • Thorin E., Pham-Dang M., Clement R., Mercier I., Calderone A. (2003). Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen. Br. J. Pharmacol. 140, 1187–1192. 10.1038/sj.bjp.0705547 [PMC free article] [PubMed] [Cross Ref]
  • Tupone D., Madden C. J., Morrison S. F. (2013). Central activation of the A1 adenosine receptor (A1AR) induces a hypothermic, torpor-like state in the rat. J. Neurosci. 33, 14512–14525. 10.1523/jneurosci.1980-13.2013 [PMC free article] [PubMed] [Cross Ref]
  • Urade Y., Hayaishi O. (2011). Prostaglandin D2 and sleep/wake regulation. Sleep Med. Rev. 15, 411–418. 10.1016/j.smrv.2011.08.003 [PubMed] [Cross Ref]
  • Velasquez S., Eugenin E. A. (2014). Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases. Front. Physiol. 5:96. 10.3389/fphys.2014.00096 [PMC free article] [PubMed] [Cross Ref]
  • Verderio C., Matteoli M. (2011). ATP in neuron-glia bidirectional signalling. Brain Res. Rev. 66, 106–114. 10.1016/j.brainresrev.2010.04.007 [PubMed] [Cross Ref]
  • Vetri F., Xu H., Mao L., Paisansathan C., Pelligrino D. A. (2011). ATP hydrolysis pathways and their contributions to pial arteriolar dilation in rats. Am. J. Physiol. Heart Circ. Physiol. 301, H1369–H1377. 10.1152/ajpheart.00556.2011 [PubMed] [Cross Ref]
  • Vitkovic L., Bockaert J., Jacque C. (2000). “Inflammatory’ cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457–471. 10.1046/j.1471-4159.2000.740457.x [PubMed] [Cross Ref]
  • Wang J., Ambrosi C., Qiu F., Jackson D. G., Sosinsky G., Dahl G. (2014). The membrane protein Pannexin1 forms two open-channel conformations depending on the mode of activation. Sci. Signal. 7:ra69. 10.1126/scisignal.2005431 [PMC free article] [PubMed] [Cross Ref]
  • Wang S., Chennupati R., Kaur H., Iring A., Wettschureck N., Offermanns S. (2016). Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J. Clin. Invest. 126, 4527–4536. 10.1172/JCI87343 [PMC free article] [PubMed] [Cross Ref]
  • Wei C. J., Li W., Chen J.-F. (2011). Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim. Biophys. Acta 1808, 1358–1379. 10.1016/j.bbamem.2010.12.018 [PubMed] [Cross Ref]
  • Weilinger N. L., Tang P. L., Thompson R. J. (2012). Anoxia-induced NMDA receptor activation opens pannexin channels via src family kinases. J. Neurosci. 32, 12579–12588. 10.1523/JNEUROSCI.1267-12.2012 [PubMed] [Cross Ref]
  • Xie L., Kang H., Xu Q., Chen M. J., Liao Y., Thiyagarajan M., et al. . (2013). Sleep drives metabolite clearance from the adult brain. Science 342, 373–377. 10.1126/science.1241224 [PMC free article] [PubMed] [Cross Ref]
  • Zhang B.-J., Huang Z.-L., Chen J.-F., Urade Y., Qu W.-M. (2017). Adenosine A2A receptor deficiency attenuates the somnogenic effect of prostaglandin D2 in mice. Acta Pharmacol. Sin. 38, 469–476. 10.1038/aps.2016.140 [PubMed] [Cross Ref]
  • Zhang Y., Laumet G., Chen S. R., Hittelman W. N., Pan H. L. (2015). Pannexin-1 up-regulation in the dorsal root ganglion contributes to neuropathic pain development. J. Biol. Chem. 290, 14647–14655. 10.1074/jbc.m115.650218 [PMC free article] [PubMed] [Cross Ref]
  • Zoidl G., Petrasch-Parwez E., Ray A., Meier C., Bunse S., Habbes H.-W., et al. . (2007). Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus. Neuroscience 146, 9–16. 10.1016/j.neuroscience.2007.01.061 [PubMed] [Cross Ref]
  • Zukowska P., Kutryb-Zajac B., Toczek M., Smolenski R. T., Slominska E. M. (2015). The role of ecto-5’-nucleotidase in endothelial dysfunction and vascular pathologies. Pharmacol. Rep. 67, 675–681. 10.1016/j.pharep.2015.05.002 [PubMed] [Cross Ref]

Articles from Frontiers in Cellular Neuroscience are provided here courtesy of Frontiers Media SA